北美血浆衍生物市场预测至 2028 年 - COVID-19 影响和区域分析（按类型（白蛋白、因子 VIII、因子 IX、免疫球蛋白、超免疫球蛋白等）、应用（血友病、低丙种球蛋白血症、免疫缺陷病、血管性血友病）疾病等）和最终用户（医院、诊所等）
No. of Pages: 137 | Report Code: BMIRE00028481 | Category: Life Sciences
No. of Pages: 137 | Report Code: BMIRE00028481 | Category: Life Sciences
根据国家罕见疾病组织的数据，A 型血友病是一种常见的 X 连锁隐性遗传病，也是继 von 后第二常见的遗传性凝血因子缺乏症维勒布兰德病。根据国家医学图书馆 (NLM) 的数据，2020 年，美国约有 30,000 至 33,000 名男性受到血友病的影响。在美国，每 5,000 名新生儿男性中约有 1 人患有 A 型血友病。根据国家罕见疾病组织的数据，到 2022 年，美国每 100 万人中约有 66 名成年人患有免疫性血小板减少症 (ITP)，这是一种自身免疫性出血性疾病。此外，在我国，成人ITP发病率为每10万人~3.3/年，患病率为每10万人9.5。此外，根据美国卫生部的数据，人类服务部称，到 2020 年，约有 100,000 名美国人患有镰状细胞病 (SCD)，这是遗传性最强的血液疾病。此外，到 2050 年，SCD 病例数量预计将增长约 30%。因此，血浆是血液中含有白细胞和血小板的液体部分。血浆衍生物在受伤后止血方面发挥着重要作用。因此，世界范围内血液疾病患病率的增加是促进血浆衍生物市场增长的主要驱动因素之一。
北美血液血浆衍生品市场已细分为美国、加拿大和墨西哥。预计美国将占据最大的市场份额。血友病和免疫缺陷病等严重疾病的流行是推动血浆衍生物市场的主要因素。根据美国疾病控制与预防中心 (CDC) 的数据，每 5,000 名男新生儿中就有 1 人患有 A 型血友病。每年大约有 400 名婴儿出生时患有 A 型血友病。美国血友病患者的确切人数尚不清楚。最近的一项研究使用了 2012 年至 2018 年期间在联邦政府资助的血友病治疗中心接受护理的患者的数据，结果显示，美国有多达 33,000 名男性患有这种疾病。
北美血浆衍生物市场按类型、应用、最终用户和国家/地区进行细分。
北美血浆衍生物市场按类型分为白蛋白、因子VIII、因子IX、免疫球蛋白、超免疫球蛋白等。到2022年，免疫球蛋白细分市场将占据更大的市场份额。
根据应用，北美血浆衍生物市场分为血友病、低丙种球蛋白血症、免疫缺陷疾病、冯维勒布兰德病等应用。到 2022 年，免疫缺陷疾病应用领域将占据最大的市场份额。
血浆衍生物市场按最终用户划分，分为医院、诊断实验室、诊所和其他最终用户。 2022 年，医院细分市场占据最大市场份额。
按国家/地区划分，北美血浆衍生物市场分为美国、加拿大和墨西哥。 2022 年，美国将主导市场。
Grifols SA； SK等离子有限公司；奥克塔制药公司；莫诺宾德公司；英塔斯制药有限公司；武田制药有限公司； CSL 贝林有限责任公司； LFB SA；和 Kedrion SpA 是北美血浆衍生品市场的领先公司。
Strategic insights for North America Blood Plasma Derivatives involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 11,821.24 Million |
| Market Size by 2028 | US$ 20,447.70 Million |
| Global CAGR (2022 - 2028) | 9.6% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2028 |
| Segments Covered |
By 类型
|
| Regions and Countries Covered | 北美
|
| Market leaders and key company profiles |
The regional scope of North America Blood Plasma Derivatives refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The North America Blood Plasma Derivatives Market is valued at US$ 11,821.24 Million in 2022, it is projected to reach US$ 20,447.70 Million by 2028.
As per our report North America Blood Plasma Derivatives Market, the market size is valued at US$ 11,821.24 Million in 2022, projecting it to reach US$ 20,447.70 Million by 2028. This translates to a CAGR of approximately 9.6% during the forecast period.
The North America Blood Plasma Derivatives Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Blood Plasma Derivatives Market report:
The North America Blood Plasma Derivatives Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Blood Plasma Derivatives Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Blood Plasma Derivatives Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For North America Blood Plasma Derivatives Market
